Pnömoniye bağlı orta akut respiratuar distres sendromunda noninvaziv mekanik ventilasyon ve yüksek akım nazal oksijen tedavisinin etkinliği

Akut Respiratuar Distres Sendromu ARDS , vasküler permeabilite artışına sekonder oluşan kardiyak olmayan akciğer ödemi ile karakterize hipoksemik solunum yetmezliği tablosudur. Yüksek mortalite ve morbidite oranına sahiptir. ARDS’nin önemli klinik özellikleri; son bir hafta içinde yeni gelişen ya da kötüleşen akciğer semptomları, bilateral radyolojik infiltrasyonlar ve oksijen tedavisine dirençli arteriyel hipoksemidir. Hastanede yatış öyküsü olmayan hastalarda ARDS’nin en sık nedeni toplumda gelişen pnömonidir. Erken dönem ARDS ve uygun olgularda entübasyondan önce noninvaziv mekanik ventilasyon NIMV ve/veya yüksek akım nazal oksijen HFNC tedavisi denenmelidir ancak bu tedavilerle yanıt alınamayan vakalarda invaziv mekanik ventilasyon İMV uygulaması geciktirilmemelidir. İki olgumuzu da toplumda gelişen pnömoniye bağlı orta ARDS yönetiminde uygulanan NIMV ve HFNC tedavisinin etkinliğini göstermek amacıyla sunuyoruz.

Efficiency of noninvasive mechanical ventilation and high flow nasal oxygen therapy in moderate acute respiratory distress syndrome due to pneumonia

Acute Respiratory Distress Syndrome ARDS is hypoxemic respiratory failure that is characterized by non-cardiac pulmonary edema secondary to increased vascular permeability. It is associated with increased mortality and morbidity. The important cilinical features of ARDS are; new or worsening symptoms during the past week, bilateral radiological infiltrations, hypoxemia refractory to oxygen therapy. Community-acquired pneumonia CAP is he most common cause of ARDS in out-patients. Noninvasive mechanical ventilation NIMV and / or high-flow nasal oxygen HFNC therapy should be applied before intubation in selected patients and the early phases of ARDS but invasive mechanical ventilation IMV should not be delayed if the patient deteriorates. We report to demonstrate efficiency of NIMV and HFNC in two cases with moderate ARDS due to CAP

___

  • 1- The ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA 2012; 307: 2526-33.
  • 2- Nishimura M. High-flow nasal cannula oxygen therapy in adults. Journal of Intensive Care 2015; 3: 15.
  • 3- Ward JJ. High-Flow Oxygen Administration by Nasal Cannula for Adult and Perinatal Patients. Respir Care 2013; 58(1): 98 –120.
  • 4- Millar J, Lutton S, O’Connor P. The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure. Ther Adv Respir Dis. 2014; 8(2): 63–4.
  • 5- Hess DE, Fessler HE. Respiratory controversies in the critical care setting. should noninvasive positivepressure ventilation be used in all forms of acute respiratory failure? Respir Care 2007; 52: 568- 78.
  • 6- Agarwal R, Aggarwal A, Gupta D. Lung injury/ acute respiratory distress syndrome: a proportion meta-analysis. Resp Care 2010; 55: 1653-60.
  • 7- Keenan S, Mehta S. Noninvasive ventilation for patients presenting with acute respiratory failure: the randomized controlled trials. Resp Care 2009; 54: 116- 26.
  • 8- Nava S, Evangelisti I, Rampulla C, Compagnoni ML, Fracchia C, Rubini F.Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure. Chest 1997; 111: 1631-8.
  • 9- Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333:817-22.
  • 10- Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure. A randomized clinical trial. Am J Respir Crit Care Med 2003; 168: 1438-44.
  • 11- Patel BK, Wolfe KS, Pohlman AS, et al. Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA 2016; 315: 2435.
  • 12- Zhan Q, Sun B, Liang L, et al. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med 2012; 40: 455.
  • 13- Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185.
  • 14- Arancibia F. Nueva definición de Berlín de Síndrome de Distrés Respiratorio Agudo. Revista chilena de medicina intensiva. 2012;27: 35–40.